All Stories

  1. Overview of Metformin and Neurodegeneration: A Comprehensive Review
  2. The Influence of the Protozoan Giardia lamblia on the Modulation of the Immune System and Alterations in Host Glucose and Lipid Metabolism
  3. Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis
  4. Uncovering miRNA–mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors
  5. Association of Glutathione Peroxidase 3 (GPx3) and miR-196a with Carbohydrate Metabolism Disorders in the Elderly
  6. Epigenetic regulation of inflammation in insulin resistance
  7. Considerations about Cytotoxicity of Resin-Based Composite Dental Materials: A Systematic Review
  8. Non-Alcoholic Fatty Liver Disease Is Associated with a Decreased Catalase (CAT) Level, CT Genotypes and the T Allele of the -262 C/T CAT Polymorphism
  9. The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?
  10. Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
  11. Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels)
  12. Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
  13. The Effect of β-Carotene, Tocopherols and Ascorbic Acid as Anti-Oxidant Molecules on Human and Animal In Vitro/In Vivo Studies: A Review of Research Design and Analytical Techniques Used
  14. Metabolic Action of Metformin
  15. Multifunctional Silver(I) Complexes with Metronidazole Drug Reveal Antimicrobial Properties and Antitumor Activity against Human Hepatoma and Colorectal Adenocarcinoma Cells
  16. The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders?
  17. Chronic and Intermittent Hyperglycemia Modulates Expression of Key Molecules of PI3K/AKT Pathway in Differentiating Human Visceral Adipocytes
  18. Chronic and Transient Hyperglycemia Induces Changes in the Expression Patterns of IL6 and ADIPOQ Genes and Their Associated Epigenetic Modifications in Differentiating Human Visceral Adipocytes
  19. Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus?
  20. A potential role of calpains in sulfonylureas (SUs) –mediated death of human pancreatic cancer cells (1.2B4)
  21. Visceral Adipose Tissue of Prediabetic and Diabetic Females Shares a Set of Similarly Upregulated microRNAs Functionally Annotated to Inflammation, Oxidative Stress and Insulin Signaling
  22. Light Stability, Pro-Apoptotic and Genotoxic Properties of Silver (I) Complexes of Metronidazole and 4-Hydroxymethylpyridine against Pancreatic Cancer Cells In Vitro
  23. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness
  24. The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress
  25. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders
  26. The Phenotype of Elderly Patients with Type 2 Diabetes Mellitus and Poor Sleep Quality
  27. Role of PI3K/AKT Pathway in Insulin-Mediated Glucose Uptake
  28. Aberrant Protein Phosphorylation in Cancer by Using Raman Biomarkers
  29. Silencing Lysine-Specific Histone Demethylase 1 (LSD1) Causes Increased HP1-Positive Chromatin, Stimulation of DNA Repair Processes, and Dysregulation of Proliferation by Chk1 Phosphorylation in Human Endothelial Cells
  30. Molecular Insight into the Interaction between Epigenetics and Leptin in Metabolic Disorders
  31. Vitamin D Supplementation Reduces Both Oxidative DNA Damage and Insulin Resistance in the Elderly with Metabolic Disorders
  32. Mitochondrial DNA copy number, damage, repair and degradation in depressive disorder
  33. Analysis of Association between Vitamin D Deficiency and Insulin Resistance
  34. Novel strategies of Raman imaging for exploring cancer lipid reprogramming
  35. Hyperglycemia Affects miRNAs Expression Pattern during Adipogenesis of Human Visceral Adipocytes—Is Memorization Involved?
  36. Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
  37. SIRT1 as a Therapeutic Target in Diabetic Complications
  38. Decreased expression level of BER genes in Alzheimer's disease patients is not derivative of their DNA methylation status
  39. Erratum to “Is p53 Involved in Tissue-Specific Insulin Resistance Formation?”
  40. Is p53 Involved in Tissue-Specific Insulin Resistance Formation?
  41. MicroRNAs and metabolic disorders – where are we heading?
  42. Tumour protein 53 is linked with type 2 diabetes mellitus
  43. The levels of 7,8-dihydrodeoxyguanosine (8-oxoG) and 8-oxoguanine DNA glycosylase 1 (OGG1) – A potential diagnostic biomarkers of Alzheimer's disease
  44. Impact of Single Nucleotide Polymorphisms of Base Excision Repair Genes on DNA Damage and Efficiency of DNA Repair in Recurrent Depression Disorder
  45. Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53
  46. Genetic polymorphisms (Pro197Leu of Gpx1, +35A/C of SOD1, −262C/T of CAT), the level of antioxidant proteins (GPx1, SOD1, CAT) and the risk of distal symmetric polyneuropathy in Polish patients with type 2 diabetes mellitus
  47. Associations between DNA Damage, DNA Base Excision Repair Gene Variability and Alzheimer's Disease Risk
  48. Epigenetic modifications in adipose tissue – relation to obesity and diabetes
  49. Analysis of oxidative DNA damage and its repair in Polish patients with diabetes mellitus type 2: Role in pathogenesis of diabetic neuropathy
  50. Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death
  51. Genotoxicity and cytotoxicity of ZnO and Al2O3nanoparticles
  52. Acute and Chronic Complications
  53. DNA damage and efficacy of DNA repair in patients with type 2 diabetes and coexisting colorectal cancer
  54. Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B
  55. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy
  56. Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells
  57. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM)
  58. Effect of gliclazide on DNA damage in human peripheral blood lymphocytes and insulinoma mouse cells